Abstract:Abstract Background Silicosis is a progressive pneumoconiosis characterized by interstitial fibrosis following exposure to silica dust. This study aimed to identify potential noninvasive metabolic biomarkers for the diagnosis and monitoring of this condition by pilot and validation analyses of patients with silicosis in metabolomics studies. Methods Patients with silicosis, dust-exposed workers (DEWs) without silicosis and age-matched healthy controls were recruited in a case-control study. Plasma samples were collected, and metabolomics analyses by ultra-high-performance liquid chromatography-mass spectrometry (UHPLC-MS) were conducted. Distinct metabolic features (DMFs) among the groups were identified in the pilot study and were validated in the validation study. The enriched signalling pathways of these DMFs were determined. The ability of DMFs to discriminate among the groups in the validation study was analysed through receiver operating characteristic (ROC) curves. The correlations between DMFs and clinical features were also explored. Results Twenty-nine DMFs and 9 DMFs were detected in the plasma of the DEW and silicosis groups, respectively, compared with the control group; these features showed the same trend in the pilot study and the validation study. Sphingolipid metabolism was the major metabolic pathway in the DEWs, and arginine and proline metabolism was associated with silicosis. Twenty DMFs in the DEWs and 3 DMFs in the patients with silicosis showed a discriminatory ability with ROC curve analysis. The abundance of kynurenine was higher in Stage III silicosis than in Stage I or Stage II silicosis. L-arginine and kynurenine were both negatively correlated with the percentage of forced vital capacity predicted in silicosis. Conclusions Distinct metabolic features of plasma samples related to sphingolipid metabolism and arginine and proline metabolism were identified in the DEW and silicosis groups, respectively. L-arginine and kynurenine may have a predictive role in the diagnosis and severity of silicosis.

Exploratory study on noninvasive biomarker of silicosis in exhaled breath by solid-phase microextraction–gas chromatography–mass spectrometry analysis

Solid Phase Microextraction for Analysis of Alkanes and Aromatic Hydrocarbons in Human Breath

The research on early detection of lung cancer with exhaled volatile organic compounds

Investigation and Application of Exhaled Breath Condensate Analysis in Lung Cancer

A Study of the Volatile Organic Compounds Exhaled by Lung Cancer Cells in Vitro for Breath Diagnosis

Rapid, Non-Invasive Breath Analysis for Enhancing Detection of Silicosis Using Mass Spectrometry and Interpretable Machine Learning

Engineering solutions to breath tests based on an e-nose system for silicosis screening and early detection in miners

Optimization of Volatile Markers of Lung Cancer to Exclude Interferences of Non-Malignant Disease

Spme-Gc Analysis of Alkanes and Aromatic Hydrocarbons in Human Breath to Screen Lung Cancer

Diagnostic performance of distinct metabolic features in the plasma of patients with silicosis

Biomonitoring Exposure and Early Diagnosis in Silicosis: A Comprehensive Review of the Current Literature

Exploration study on serum metabolic profiles of Chinese male patients with artificial stone silicosis, silicosis, and coal worker's pneumoconiosis

The value of single biomarkers in the diagnosis of silicosis: A meta-analysis

Combined application of multiple biomarkers for early auxiliary diagnosis of silicosis

Exosomal proteomics and cytokine analysis distinguish silicosis cases from controls

Quantitation of Silica Contents in Lung Explants of Transplanted Patients: Artificial Stone-Induced Silicosis vs. Idiopathic Pulmonary Fibrosis

Integrating routine blood biomarkers and artificial intelligence for supporting diagnosis of silicosis in engineered stone workers

Integrated mRNA and microRNA profiling in lung tissue and blood from human silicosis

Label-free Raman spectroscopy characterizes signatures of inflammation and fibrosis in the silicosis

Early Identification, Accurate Diagnosis, and Treatment of Silicosis

Biomarkers: A potential prognostic tool for silicosis